NCT00000337View on ClinicalTrials.gov

Infusion Laboratory: Protocol 1 - Selegeline - 2

PHASE1CompletedINTERVENTIONAL

0

Timeline

Start Date

November 30, 1994

Conditions

Cocaine-Related Disorders

Interventions

DRUG

Selegiline

Trial Locations (1)

90025

Friends Research Institute, Los Angeles

All Listed Sponsors

lead

National Institute on Drug Abuse (NIDA)

NIH